Trials / Completed
CompletedNCT02179333
Preliminary Study of the Scale To Assess Ataxia and Neurologic Dysfunction (STAND)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- University of South Florida · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The objectives of this study are: * To validate the inter-rater and intra-rater reliability of a new scale for the assessment of ataxia and neurologic dysfunction (STAND) * To assess common constructs and correlation between STAND subscale items.
Detailed description
There are few validated, comprehensive rating scales for the assessment of ataxia severity. The development of a Scale To assess Ataxia and Neurologic Dysfunction (STAND) would examine and measure as many facets of ataxia as possible. Scale items to be measured include parkinsonism, timed gait analysis, dystonia, neuropathy and peripheral nerve weakness, as well as other areas of clinical manifestation for ataxia. This brief but thorough scale should yield a thorough measurement of ataxia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Ataxia rating scale | Administer new rating scale for ataxia. This will be administered by two different raters on two separate occassions, 4 to 6 weeks apart. |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2016-06-01
- Completion
- 2016-06-01
- First posted
- 2014-07-01
- Last updated
- 2021-11-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02179333. Inclusion in this directory is not an endorsement.